The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I have been invested in PHNX for over 2 years and in that time it has been a rollercoaster for the SP but steady on the Divi. What seems different this time is the under performance of the SP as we near the March statement. The SP has traditionally risen, but fear of another series of bank collapses is dragging the financials sector down. I only hope the clouds gathering around NYCB do not lead to another correction
If they have 12.5 billion in the bank, and they are actively looking at adding through M&A. This bodes well for the coming months. However, we have to get over these interest hikes. Liquidity will move towards high-yielding bonds as a safe haven on return. Add to that the "Elliot Wave Gurus" are predicting a 10% downturn in the SnP 500 between now and Xmas. This will have a short-term knock-on for all stocks. So get your crystal balls out and put your wet finger to the sky
DYOR
How sustainable is that dividend? Phoenix has a business generating £12.5 billion of free cash, after the repayment of debt and interest costs. That would cover the £520 million cost of the annual dividend as it stands for more than 20 years, without Phoenix writing any new business or mergers and acquisition deals.
The effect of these rules is that when the same shares are ultimately sold, the original acquisition cost rather than the repurchase cost will be used to calculate the capital gain.
If you buy these shares back( within 30 days) under your 383p price (I.E 360p/share) you will be booked a 23p Capital Gain.
Liquidity is also a massive problem for Stocks going forward. For the first time in decades, money can be made by locking into a 6% fixed savings account. For many people, this is a dilemma. Do you take a guaranteed return, or risk it in a market of uncertainty?
The official M&G website is highly likely to be right. This may explain why the SP is sluggish. Historically the share price moves up in line with the expectation of the Divi being announced. If correct we are 6-8 weeks away from any news
Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology, focused on sexual health, today announces that it has entered into a ground breaking licensing agreement with Haleon plc ("Haleon"), a world leading consumer healthcare Company for the rights to exclusively commercialise the Company's innovative topical, gel-based Erectile Dysfunction ("ED") treatment MED3000, in the USA.
IAG is a bit undervalued compared to other companies in the industry. Data shows that the company has a PE ratio of 8.1x compared to the overall average of 12. Additional data compiled by Simply Wall Street shows that the fair value of 979p per share